Apella Capital
VRTX icon

Apella Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Apella Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$569K Buy
1,125
+522
+87% +$267K 0.01% 484
2026
Q2 		$315K Buy
+603
New +$267K ﹤0.01% 572

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Provident Investment Management
Provident Investment Management Novi, Michigan $999M AUM 19.45% 1-Year Est. Return

Apella Capital's VRTX Position: Q3 2026 in Review

Apella Capital increased its Vertex Pharmaceuticals (VRTX) stake by 87% in Q3 2026, buying an estimated $267K and bringing the position to 1,125 shares worth $569K. The position accounts for 0.01% of the portfolio, ranked #484.

Apella Capital first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 530 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Apella Capital held 1,125 shares of Vertex Pharmaceuticals worth $569K as of Q3 2026.
  • Apella Capital bought 522 Vertex Pharmaceuticals shares in Q3 2026, an estimated $267K.
  • Vertex Pharmaceuticals made up 0.01% of Apella Capital's portfolio in Q3 2026, its #484 holding.
  • Apella Capital first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 530 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.